Posttransplant thrombotic microangiopathy: Sensitivity of proposed new diagnostic criteria

Transfusion

Volumn 49, Issue 9, 2009, Pages 1884-1889

  Kennedy, Glen A ^a   Bleakley, Shane ^a   Butler, Jason ^a   Mudie, Kari ^a   Kearey, Natasha ^a   Durrant, Simon ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN; IMMUNOGLOBULIN ANTIBODY; LACTATE DEHYDROGENASE;

ADULT; ANEMIA; ARTICLE; BONE MARROW TRANSPLANT CLINICAL TRIALS NETWORK CRITERIA; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; DIAGNOSTIC ERROR; ERYTHROCYTE; FEMALE; HUMAN; INTERNATIONAL WORKING GROUP CRITERIA; KIDNEY DYSFUNCTION; LABORATORY TEST; MALE; NEUROLOGIC DISEASE; POSTTRANSPLANT THROMBOTIC MICROANGIOPATHY; SENSITIVITY AND SPECIFICITY; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOSIS; YOUNG ADULT;

EID: 69249197783     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02217.x     Document Type: Article

References (30)

1. George JN, Xiaoning L, McMinn JR, Terrell DR, Vesely SK, Selby GB. Thrombotic thrombocytopenia purpura-hemolytic uremic syndrome following HPC transplantation: a diagnostic dilemma. Transfusion 2004 44 : 294 304.
2. Batts ED, Lazarus HM. Diagnosis and treatment of transplantation- associated thrombotic microangiopathy: real progress or are we still waiting? Bone Marrow Transplant 2007 40 : 709 19.
3. Daly AS, Xenocostas A, Lipton JH. Transplantation associated thrombotic microangiopathy: twenty-two years later. Bone Marrow Transplant 2002 30 : 709 15.
4. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994 14 : 495 504.
5. Kanamori H, Takaishi Y, Takabayashi M, Tanaka M, Yamaji S, Tomita N, Fujimaki K, Fujisawa S, Watanabe S, Matsuzaki M, Ishigatsubo Y. Clinical significance of fragmented red cells after allogeneic bone marrow transplantation. Int J Hematol 2003 77 : 180 4.
6. Kersting S, Koomans HA, Hene RJ, Verdonck LF. Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival. Bone Marrow Transplant 2007 34 : 359 64.
7. Reece DE, Frei-Lahr DA, Shepherd JD, Dorovini-Zis K, Gascoyne RD, Graeb DA, Spinelli JJ, Barnett MJ, Klingemann HG, Herzig GP. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporine. Bone Marrow Transplant 1991 8 : 393 401.
8. Martinez MT, Ch B, Stussi G, Heim D, Buser A, Tsakiris TA, Tichelli A, Gratwohl A, Passwg JR. Transplant associated microangiopathy in recipients of allogeneic hematopoietic stem cell transplants. Bone Marrow Transplant 2005 36 : 993 1000. (Pubitemid 41741563)
9. Roy V, Rizvi MA, Vesely SA, George JN. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant 2001 27 : 641 6.
10. Elliot MA, Nichols WL, Plumhoff E, Ansell S, Dispenzieri A, Gastineau D, Gertz MA, Inwards DJ, Lacy MQ, Micallef IN, Tefferi A, Litzow M. Posttransplantation thrombocytopenic purpura: a single centre experience and a contemporary review. Mayo Clin Proc 2003 78 : 421 30.
11. Uderzo C, Bonanomi S, Busca A, Renoldi M, Ferrari P, Iacobelli M, Morreale G, Lanino E, Annaloro C, Volpe AD, Alessandrino P, Longoni D, Locatelli F, Sangalli H, Rovelli A. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation 2006 82 : 638 44.
12. Zeigler ZR, Shadduck RK, Nemunaitis J, Andrews DF, Rosenfeld CS. Bone marrow transplant-associated thrombotic microangiopathy: a case series. Bone Marrow Transplant 1995 15 : 247 53.
13. Iacopino P, Pucci G, Arcese W, Bosi A, Falda M, Locatelli F, Marenco P, Miniero R, Morabito F, Rossetti F, Sica S, Uderzo C, Bacigalupo A. Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation. Bone Marrow Transplant 1999 24 : 47 51. (Pubitemid 29346604)
14. Fuge R, Bird JM, Fraser A, Hart D, Hunt L, Cornish JM, Goulden N, Oakhill A, Pamphilon DH, Steward CG, Marks DI. The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. Br J Haematol 2001 113 : 58 64.
15. Nakamae H, Yamane T, Hasegawa T, Nakamae M, Terada Y, Hagihara K, Ohta K, Hino M. Risk factor analysis for thrombotic microangiopathy after reduced intensity or myeloablative allogeneic hematopoietic stem cell transplantation. Am J Hematol 2006 81 : 525 31.
16. Holler E, Kolb HJ, Hiller E, Mraz W, Lehmacher W, Gleixner B, Seeber C, Jehn U, Gerhartz HH, Brehm G. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989 73 : 2018 24.
17. Sarkodee-Adoo C, Sotirescu D, Sensenbrenner L, Rapoport A, Cottler-Fox M, Tricot G, Ruehle K, Meisenberg B. Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A. Transfusion 2003 43 : 78 84.
18. Ruutu T, Hermans J, Niederwieser D, Gratwohl A, Kiehl M, Volin L, Bertz H, Ljungman P, Spence D, Verdonck LF, Prentice HG, Bosi A, Du Toit CE, Brinch L, Apperley JF. Thrombotic thrombocytopenic purpura after allogeneic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 2002 118 : 1112 9.
19. Van der Plas RM, Schiphorst ME, Huizinga EG, Hene RJ, Verdonck LF, Sixma JJ, Fijnheer R. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated thrombotic thrombocytopenic purpura. Blood 1999 93 : 3798 802.
20. Kentouche K, Zinti F, Angerhaus D, Fuchs D, Hermann J, Schneppenheim R, Budde U. von Willebrand factor-cleaving protease (ADAMTS13) in the course of stem cell transplantation. Semin Thromb Hemost 2006 32 : 98 104.
21. Peyvandi F, Siboni SM, Lambertenghi Deliliers D, Lavoretano S, De Fazip N, Moronoi B, Lambertenghi Deliliers G, Mannuccio Mannucci P. Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation. Br J Haematol 2006 134 : 187 95.
22. Ho VT, Cutler C, Carter S, Martin P, Adams R, Horowitz M, Ferrara J, Soiffer R, Giralt S. Blood and marrow transplant-clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2005 11 : 571 5.
23. Ruutu T, Barosi G, Benjamin RJ, Clark RE, George JN, Gratwohl A, Holler E, Iacobelli M, Kentouche K, Lammle B, Moake JL, Richardson P, Socie G, Zeigler Z, Niederwieser D, Barbui T. Diagnostic criteria for hematopoietic stem transplant associated thrombotic microangiopathy: results of a consensus process by an international working group. Haematologica 2007 92 : 95 100.
24. George JN. Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder. Bone Marrow Transplant 2008 41 : 917 8.
25. Petz DL. Bystander immune cytolysis. Transfus Med Rev 2006 20 : 110 40.
26. Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S, Cho SG, Kim Y, Kim DW, Lee JW, Min WS, Kim CC. Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008 41 : 813 20.
27. Nishiyama T. Changes of haptoglobin and free hemoglobin due to blood transfusion. Middle East J Anesthesiol 1995 13 : 79 88.
28. Nishiyama T, Hanaoka K. Free haemoglobin concentration in patients receiving massive blood transfusion during emergency surgery for trauma. Can J Anesth 2000 47 : 881 5.
29. Kormoczi GP, Saemann MD, Buchta C, Peck-Radosavljevic M, Mayr WR, Schwartz DW, Dunkler D, Spitzauer S, Panzer S. Influence of clinical factors on the haemolysis marker haptoglobin. Eur J Clin Invest 2006 36 : 202 9.
30. Marchand A, Galen RS, Van Lente F. The predictive value of haptoglobin in haemolytic disease. JAMA 1980 243 : 1909 11.